Integration of Bioinformatics and Biotechnology: A Potential Insight into Antidiabetic Drug Discovery

Abstract

Diabetes mellitus is a complex non-communicable metabolic disorder that can lead to serious
health complications such as heart disease, kidney failure, blindness, and peripheral neuropathy
if not treated early. Its global prevalence is rising, demanding safer and more effective
therapeutic options. Medicinal plants have long served as sources of bioactive compounds
precursor to effective drugs against some longstanding diseases. However, there is variability
in the phytochemical composition of plant material collected from the natural environment,
especially due to environmental factors, seasonal changes, and genetic variation, which often
limit research reproducibility. This review highlights integration of bioinformatics and
biotechnology may address these challenges and improve drug discovery efficiency.
Bioinformatics tools, especially molecular docking and ADMET prediction, enable the easy
and quick identification and evaluation of plant-derived compounds targeting key diabetic
proteins like insulin receptors, Glucagon-like peptide 1 (GLP-1), dipeptidyl peptidase -4 (DPP-
4) inhibitors and Glucose-dependent insulinotropic polypeptide (GIP) . These computational
approaches reduce time, cost, and experimental uncertainty while predicting drug-like
properties prior to in vitro or in vivo validations. Complementarily, biotechnology techniques
such as tissue culture ensure the consistent production of genetically stable, disease-free plant
materials rich in secondary metabolites independent of seasonal or environmental variations.
Analytical methods like HPLC, GC-MS, and NMR further aid in compound isolation and
characterization for further research to validate the potency of the identified and isolated
compounds. Integration of bioinformatics and biotechnology therefore bridges the traditional
medicinal plant research and modern drug discovery, ensuring reproducibility, standardization,
and biodiversity conservation for antidiabetic drug discovery